NCT01956149View on ClinicalTrials.gov

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

April 4, 2018

Conditions
Gastric Cancer
Interventions
DRUG

Cabazitaxel

20 mg/m2 over 1 hour i.v., repeated on day 22 for maximum 6 cycles.

Trial Locations (3)

60488

Krankenhaus Nordwest, Frankfurt am Main

Unknown

Krankenhaus Dresden Friedrichstadt, Dresden

07747

Universitätsklinikum Jena, Jena

All Listed Sponsors
lead

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

OTHER

NCT01956149 - Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer | Biotech Hunter | Biotech Hunter